A therapy is a cure for health problems, which normally is administered after the diagnosis of the patient. The therapeutic equipments and services mainly cater to the home healthcare segment such as physical therapies or speech therapies. The sectio ....see more
The global cold plasma market in terms of revenue was estimated to be worth $1.6 billion in 2021 and is poised to reach $3.3 billion by 2026, growing at a CAGR of 15.0% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global diabetes care devices market in terms of revenue was estimated to be worth $1.7 billion in 2020 and is poised to reach $4.3 billion by 2025, growing at a CAGR of 16.2% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
The global apheresis market boasts a total value of $1.7 billion in 2019 and is projected to register a growth rate of 8.1% to reach a value of $2.7 billion by 2025. The key players in the global apheresis market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan).
The ophthalmic lasers market size is projected to grow at a CAGR of 5.1%. Increasing prevalence of ophthalmic disorders, rising prevalence of chronic disorders, rapid growth in geriatric population, and increasing regulatory approvals for ophthalmic lasers are expected to drive the growth of this market.
The critical care equipment market for asia and north Africa is expected to reach $2.61 billion by 2021 from $1.78 billion in 2016, at a CAGR of 8.0% during the forecast period. Continuous technological advancements in critical care devices, increasing government support, growing private sector investments in the healthcare industry, and increasing patient population base are key factors fuelling the growth of the global market of critical care equipment in the emerging nations.
Global ophthalmology drug and devices market is witnessing a significant growth due to the increasing incidence and prevalence of eye related disorders such as presbyopia, macular degeneration, and diabetic retinopathy among the aging population. With the introduction of ophthalmic devices equipped with sophisticated technologies, people are increasingly opting for ophthalmic surgeries to correct their eye related disorders.
This market report will enable strategic understanding on the ophthalmology devices & drugs market. Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass more than 40 company profiles.
Dental consumables form the largest segment of the dental industry, and also hold significant potential for further growth due to the increasing incidence of oral disease and growing awareness about oral care. The growth of the dental consumables market is also driven by the demand from the increasing population of aging people across the globe, as well as from the younger generation focusing on dental aesthetics.
The report provides market data on the latest and future equipment and technologies in the market. It also analyzes the key market trends, strategies of the key players and provides market data for the next five years. The focus is on the patented equipment and technologies being developed across the globe.